Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Infect Dis. 2024 Sep 23;230(3):763-767. doi: 10.1093/infdis/jiae043.
Invasive fungal pathogen Candida auris has become a public health threat causing outbreaks of high mortality infections. Drug resistance often limits treatment options. For Candida albicans, subinhibitory concentrations of echinocandins unmask immunostimulatory β-glucan, augmenting immunity. Here we analyze the impact of echinocandin treatment of C. auris on β-glucan exposure and human neutrophil interactions. We show subinhibitory concentrations lead to minimal glucan unmasking and only subtle influences on neutrophil functions for the isolates belonging to circulating clades. The data suggest that echinocandin treatment will not largely alter phagocytic responses. Glucan masking pathways appear to differ between C. auris and C. albicans.
侵袭性真菌病原体耳念珠菌已成为公共卫生威胁,导致高死亡率感染的爆发。药物耐药性常常限制了治疗选择。对于白色念珠菌,棘白菌素的亚抑菌浓度揭示了免疫刺激性β-葡聚糖,增强了免疫力。在这里,我们分析了棘白菌素治疗耳念珠菌对β-葡聚糖暴露和人中性粒细胞相互作用的影响。我们发现,亚抑菌浓度只会导致最小程度的葡聚糖暴露,并且对属于循环谱系的分离株的中性粒细胞功能只有细微影响。数据表明,棘白菌素治疗不会大大改变吞噬反应。葡聚糖掩蔽途径在耳念珠菌和白色念珠菌之间似乎不同。